Table of Contents Table of Contents
Previous Page  196-197 / 427 Next Page
Information
Show Menu
Previous Page 196-197 / 427 Next Page
Page Background

Adulteration of Dietary Supplements 

with Synthetic PDE5 Inhibitors

Serious problem

i l

i

d (

l h l) h l h ff

Potent a ser ous a verse even et a ea t a ects

Adulteration with approved drugs but also their 

unapproved analogs (unknown toxicological effects)

High incidence of adulteration

Campbell

et al

., 

J. Sex. Med.

10 (2013) 1842‐1849:

81%

out of 91 tested

herbal products adulterated 

with synthetic PDE5 inhibitors and their analogs